;)
Dave is a distinguished leader in the contract manufacturing and development sector of the biotech industry, specializing in cell and gene therapies. In his over two decades of experience, Dave has been Founder/CEO of CDMO Molecular Medicine BioServices, served as Chief Commercial Officer at Oxford Biomedica, and had senior management roles at ElevateBio and MilliporeSigma which further underscore his cell and gene therapy expertise. Dave’s broad industry experience and strategic acumen make him an invaluable asset to our board, guiding our company through its critical growth and innovation phases.
Dave holds an MBA from the University of Chicago Booth School of Business, and he earned his Bachelor of Science in Cellular and Molecular Biology from the University of Michigan.